Biotech

All Articles

OS Treatments refiles $6M IPO to fund HER2 medicine, preclinical ADCs

.Operating system Therapies are going to note on the NYSE American sell exchange this morning throug...

ALX's waning CD47 action cost delivers sell spiraling down

.ALX Oncology's period 2 gastric cancer cells feedback price has actually weakened. After finding it...

Ionis axes eye illness coming from aim ats of Roche-partnered prospect after data let down

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has disappointed assumptions, mot...

Biogen's chief executive officer said no unsafe handle 2023. He's ready to become bold

.While Biogen's pharma peers are actually seeking for late-stage assets along with little threat, ch...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Bio has been a biotech in search of a pipeline after it ditched its own lead possessions ove...

Biogen ignores Denali Alzheimer's collab

.Biogen has actually restored legal rights to a very early Alzheimer's illness system to Denali Ther...

Takeda taps new head of US oncology business-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable leadership hirings, firings as wel...

Vertex, hammered by AATD once again, falls 2 resources on throw out heap

.Tip's effort to treat an unusual hereditary condition has hit yet another obstacle. The biotech sho...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of team

.Vir Biotechnology's second-quarter earnings document wasn't except large information. The business ...

Galapagos stops briefly CAR-T tissue therapy hearing over Parkinsonism instance

.Galapagos has stopped enrollment in a test of a BCMA-directed CAR-T cell treatment, pushing the bra...